China Medical Beigang Hospital was approved by the Taiwan FDA for “Stage I to III Solid Cancers after ineffective conventional treatment on autologous dendritic cell therapy

China Medical Beigang Hospital was approved by the Taiwan FDA for “Stage I to III Solid Cancers after ineffective conventional treatment on autologous dendritic cell therapy

China Medical Beigang Hospital is one of the Ever Supreme’s collaborating medical facility that received approved by the Taiwan FDA on autologous dendritic cells (abbreviated as DC) therapy for “Stage I to III solid cancers that have ineffective conventional treatment” on August of 2020.  DC therapy provides patients who meet the conditions for admission in the indications: Grade 1 to Grade 2 low-grade glioma and highly Grade 3 glioma, epithelial ovarian cancer, pancreatic cancer Visceral cancer, prostate cancer, head and neck cancer, liver cancer, breast cancer, and colorectal cancer.

BACK